Iovance Biotherapeutics Inc. (IOVA)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
1 |
$503,000 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 20 Feb 2024 |
MCPEAK MERRILL A |
Director |
20 Feb 2024 |
250,000 |
9.15 |
2,287,500 |
| 20 Feb 2024 |
DUKES IAIN D. |
Director |
20 Feb 2024 |
32,000 |
9.15 |
292,800 |
| 20 Feb 2024 |
ROTHBAUM WAYNE P. |
Director |
20 Feb 2024 |
5,000,000 |
9.15 |
45,750,000 |
| 19 Sep 2023 |
MCPEAK MERRILL A |
Director |
18 Sep 2023 |
10,000 |
5.56 |
55,600 |
| 15 Sep 2023 |
ROTHBAUM WAYNE P. |
Director |
15 Sep 2023 |
5,000,000 |
5.30 |
26,500,000 |
| 22 Dec 2022 |
MCPEAK MERRILL A |
Director |
21 Dec 2022 |
10,000 |
6.15 |
61,500 |
| 02 Dec 2022 |
ROTHBAUM WAYNE P. |
Director |
02 Dec 2022 |
10,000,000 |
6.50 |
65,000,000 |
| 30 Nov 2022 |
MCPEAK MERRILL A |
Director |
29 Nov 2022 |
10,000 |
6.31 |
63,100 |
| 28 Nov 2022 |
VOGT FREDERICK G |
Interim CEO & General Counsel |
28 Nov 2022 |
1,000 |
5.98 |
5,980 |
| 28 Nov 2022 |
MCPEAK MERRILL A |
Director |
28 Nov 2022 |
10,000 |
6.18 |
61,800 |
| 28 Nov 2022 |
DUKES IAIN D. |
Director |
23 Nov 2022 |
10,000 |
6.10 |
61,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock